In brief

Increased inflammation causes a decline in the number of stem cell memory T cells, resulting in poorer immunity as we age.

© Shutterstock

Turning back the immunological clock

7 Apr 2021

The discovery of how aging impacts memory T cells may unlock novel therapeutic targets to boost immune protection in older adults.

The immune system is a fortress, defending the body against the constant threat of invasion by bacteria, viruses and other microorganisms. This protection is lifelong: immune cells remain vigilant for infectious agents that we may have encountered, naturally or through vaccinations, decades ago.

T cells are responsible for keeping track of these pathogenic encounters by differentiating and dividing into specialized subpopulations. “This generates a pool of memory T cells which can recognize the same antigen when it reappears later in life. They comprise the memory of the immune system,” explains Anis Larbi, a Principal Investigator at A*STAR’s Singapore Immunology Network (SIgN) and a co-corresponding author of this study.

With age, however, cracks appear in the immunological armor; elderly individuals cannot respond to immune challenges as robustly as before. To uncover the mechanisms behind the phenomenon of immune-aging, Larbi led a team of researchers to probe a recently discovered subset of memory T cells, called stem cell memory T lymphocytes (TSCM). Could a drop in the self-renewal capacity of TSCM explain why seniors are more susceptible to complications following infections?

Larbi’s team, in collaboration with Tze Pin Ng at the National University Health System (NUHS) and international collaborators from Italy, Malaysia, Spain and Germany, used a combination of technologies to piece this puzzle together, one cell at a time.

With high-dimensional flow cytometry, the team panned heterogeneous populations of T cells to pick out TSCM based on their molecular signature. They then characterized these TSCM using biomarkers of senescence and aging, isolating samples of TSCM from elderly Singaporeans. Next, single-cell RNA sequencing allowed the researchers to accurately define subsets of these aged T cells based on their RNA profile and investigate how RNA signatures may be altered in aging.

Their findings confirmed that with aging, TSCM populations take a nosedive. The root causes of this were revealed to be two-fold: chronic inflammation contributed to their decline while disruption in the Wnt/β-catenin pathway in TSCM precursor cells affected their downstream development.

“We have shown that maintaining early precursors, the naïve T cells, is an important aspect to sustain immunity in older age,” Larbi said. “As inflamm-aging is observed in conjunction with a drop in numbers and quality of TSCM, better controlling the inflammatory process in older age may boost the functional capacity of TSCM, to rejuvenate memory T cell responses.”

According to the scientists, both pathways can be leveraged as potential therapeutic targets to reverse immune-related aging. Ongoing studies are focused on tracking development versus the early onset of senescence in T cells, with the view of developing more effective vaccines and immunotherapies for the elderly. TSCM function and diversity may also be restored through the calibrated use of Wnt/β-catenin agonists, they propose.

The A*STAR-affiliated researchers contributing to this research are from the Singapore Immunology Network (SIgN).

Want to stay up to date with breakthroughs from A*STAR? Follow us on Twitter and LinkedIn!


Kared, H., Tan, S.W., Lau, M.C., Chevrier, M., Tan, C., et al. Immunological history governs human stem cell memory CD4 heterogeneity via the Wnt signaling pathway. Nature Communications 11, 821 (2020) | article

About the Researcher

View articles

Anis Larbi

Principal Investigator

Singapore Immunology Network
Anis Larbi graduated from the University of Sherbrooke, Canada, in 2005, where he performed immunological studies on aging at the Laboratory of Immunity/Signaling in the Clinical Research Center, Faculty of Medicine. He then studied immunological aging at the Center for Medical Research at the University of Tubingen, Germany, where he focused on the impact of chronic infectious agents such as cytomegalovirus on the immunity of the elderly. There, he also developed his skills in multi-parametric flow cytometry. In February 2010, he joined A*STAR’s Singapore Immunology Network (SIgN) to fulfil two missions: develop a program on immunity in aging humans and set up a competitive flow cytometry facility at SIgN. Larbi has published more than 190 papers in the field of immunological analysis, many of which involve flow cytometry techniques. He is an Emeritus Scholar of the International Society for Advancement of Cytometry (ISAC).

This article was made for A*STAR Research by Wildtype Media Group